Company / Operating Margin
Cyclerion Therapeutics, Inc. Operating Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-239.8%
FY2025
5-year range
-6242.4% / -239.8%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -6242.4% to -239.8% over the past 3 years.
Based on SEC 10-K filings.
-239.8% in FY2025 with a 5-year CAGR of +2534.5%.
Improved from -6242.4% to -239.8% over the past 3 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +6002.6pp
- 5-Year Change
- +2534.5pp
- 10-Year Change
- -
Key checks
Key Insights
- Lowest operating margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -239.8% | - |
| FY2024 | - | - |
| FY2023 | -6242.4% | +0.0% |
| FY2022 | -6242.4% | -76.4% |
| FY2021 | -3539.4% | -27.6% |
| FY2020 | -2774.3% | -8.5% |
| FY2019 | -2557.2% | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026